Zymeworks Inc (ZYME)
9.12
+0.06
(+0.66%)
USD |
NASDAQ |
May 07, 16:00
9.41
+0.29
(+3.18%)
After-Hours: 20:00
Zymeworks Enterprise Value: 299.78M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 299.78M |
| May 06, 2024 | 295.54M |
| May 03, 2024 | 305.44M |
| May 02, 2024 | 291.30M |
| May 01, 2024 | 274.33M |
| April 30, 2024 | 261.60M |
| April 29, 2024 | 243.69M |
| April 26, 2024 | 238.75M |
| April 25, 2024 | 228.14M |
| April 24, 2024 | 259.24M |
| April 23, 2024 | 259.95M |
| April 22, 2024 | 270.55M |
| April 19, 2024 | 280.45M |
| April 18, 2024 | 267.72M |
| April 17, 2024 | 280.45M |
| April 16, 2024 | 286.10M |
| April 15, 2024 | 297.41M |
| April 12, 2024 | 308.72M |
| April 11, 2024 | 316.49M |
| April 10, 2024 | 297.41M |
| April 09, 2024 | 316.49M |
| April 08, 2024 | 334.87M |
| April 05, 2024 | 336.99M |
| April 04, 2024 | 337.69M |
| April 03, 2024 | 335.57M |
| Date | Value |
|---|---|
| April 02, 2024 | 307.30M |
| April 01, 2024 | 353.24M |
| March 31, 2024 | 398.48M |
| March 28, 2024 | 368.05M |
| March 27, 2024 | 352.53M |
| March 26, 2024 | 364.52M |
| March 25, 2024 | 359.58M |
| March 22, 2024 | 368.05M |
| March 21, 2024 | 377.22M |
| March 20, 2024 | 384.28M |
| March 19, 2024 | 368.76M |
| March 18, 2024 | 381.46M |
| March 15, 2024 | 388.52M |
| March 14, 2024 | 385.69M |
| March 13, 2024 | 384.28M |
| March 12, 2024 | 388.52M |
| March 11, 2024 | 405.45M |
| March 08, 2024 | 432.97M |
| March 07, 2024 | 432.97M |
| March 06, 2024 | 488.72M |
| March 05, 2024 | 471.08M |
| March 04, 2024 | 508.48M |
| March 01, 2024 | 508.03M |
| February 29, 2024 | 472.76M |
| February 28, 2024 | 471.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-22.08M
Minimum
Apr 26 2022
2.189B
Maximum
Jan 08 2021
685.27M
Average
490.38M
Median
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.058B |
| MariMed Inc | 161.91M |
| Viemed Healthcare Inc | 291.99M |
| NovaBay Pharmaceuticals Inc | 2.560M |
| Palatin Technologies Inc | 24.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.65M |
| Revenue (Quarterly) | 10.03M |
| Total Expenses (Quarterly) | 47.83M |
| EPS Diluted (Quarterly) | -0.42 |
| Profit Margin (Quarterly) | -315.6% |
| Earnings Yield | -19.52% |
| Normalized Earnings Yield | -19.45 |